News

May 28, 2019May 28, 2019

Slow Speed Resistance Exercise for Children Can Lead to Improved Energy, Study Says

News

Slow speed resistance exercise is safe and well-tolerated by children with juvenile idiopathic arthritis, and can lead to slight reductions in fatigue and mild improvements in energy, a study says. ... Read more

May 21, 2019May 21, 2019

ACR and Arthritis Foundation Release New Treatment Guidelines for Juvenile Arthritis

News

New guidelines were released by the American College of Rheumatology (ACR) and the Arthritis Foundation (AF) to provide orientation to doctors and patients for the treatment of juvenile idiopathic arthritis ... Read more

May 14, 2019May 14, 2019

Orencia Safe, Effective for Children with Polyarticular JIA, Phase 3 Trial in Japan Confirms

News

Treatment with Orencia (abatacept) is well-tolerated and effective in managing disease activity in children with polyarticular juvenile idiopathic arthritis (JIA), according to results from a Phase 3 clinical trial conducted ... Read more

May 7, 2019May 7, 2019

Eticovo, a Biosimilar of Enbrel, Approved by FDA for Polyarticular JIA Patients Ages 2 and Older

News

Eticovo (etanercept-ykro), a biosimilar of Enbrel (etanercept), has been approved by the U.S. Food and Drug Administration (FDA) as a therapy for lessening symptoms in children ages two and older with ... Read more

April 30, 2019April 30, 2019

Video-Based Game Improved Hand Function in Youngsters with Juvenile Idiopathic Arthritis

News

Digital hand tracker-based training improves functions and promotes hand-pinch strength in people with juvenile idiopathic arthritis, according to new clinical data. The study with those results, “Leap Motion Controller-based training ... Read more

April 26, 2019April 26, 2019

Children at Various Stages of sJIA Have Distinct Molecular Signatures, Study Says

News

German scientists have discovered that children with classic autoinflammatory systemic juvenile idiopathic arthritis (sJIA) or chronic polyarticular sJIA have different molecular signatures that can be used to distinguish them. Researchers are hopeful that ... Read more

April 23, 2019April 23, 2019

Stress Test Not Best Measure of Cardiorespiratory Fitness in Individual JIA Patients, Study Finds

News

The submaximal treadmill test — also known as the stress test — is not optimal for daily clinical use to evaluate physical function and cardiorespiratory fitness in juvenile idiopathic arthritis patients, ... Read more

April 16, 2019April 16, 2019

Testing for Cytokine May Help Detect Life-threatening Complication in Children with Systemic JIA, Study Says

News

Checking for blood levels of a small protein called CXCL9 can be a valuable biomarker for detecting macrophage activation syndrome (MAS), a potentially life-threatening complication in patients with systemic juvenile idiopathic arthritis ... Read more

April 12, 2019April 12, 2019

Case Report Supports Use of Xeljanz in Children with Systemic JIA

News

Xeljanz (tofacitinib) might be an effective and safe treatment for children with systemic juvenile idiopathic arthritis (JIA), a new case report suggests. The study, “Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic ... Read more

April 9, 2019April 9, 2019

New Enbrel Biosimilar YLB113 Is Now Available in Japan

News

Japanese patients with rheumatoid arthritis and juvenile arthritis can now be treated with a biosimilar therapy of Enbrel (etanercept). The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved the request of ... Read more